MedTrace Logo

Neutralizing Antibody Level After COVID-19 Vaccination

NCT05083026 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2023-10-04

No results posted yet for this study

Summary

1. serial of neutralizing antibody at 2, 4, 6, 9, 12 month after COVID-19 vaccination
2. investigate the factors on antibody titer.

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

COVID-19 neutralizing antibody

This study enrolled persons already who received COVID-19 vaccination under government policy. 1. We collect 5mL blood at 2, 4, 6, 9, 12 months after COVID-19 vaccination 2. isolate serum and store in -80 degree deep freezer 3. measure neutralizing Antibody

Sponsors & Collaborators

  • Kyungpook National University Hospital

    lead OTHER

Principal Investigators

  • Su Youn Nam, MD, PhD · Kyungpook National University Hospital

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-02
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05083026 on ClinicalTrials.gov